Skip to content

Clinical effect and cost-effectiveness analysis of skin protective film combined with ostomy bag and negative pressure drainage in preventing incontinence dermatitis in patients with severe acute pancreatitis

Evidence-based prevention strategy and cost-effectiveness analysis of incontinent dermatitis in patients with severe pancreatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114406
Enrollment
Unknown
Registered
2025-12-11
Start date
2023-03-16
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe acute pancreatitis

Interventions

Intervention Group:Best Evidence Summary and Improvement Plan for Incontinence-Associated Dermatitis Management in Patients with Severe Pancreatitis
Control group:Conventional incontinence-associated dermatitis management protocol

Sponsors

Hunan Provincial People's Hospital (the first affiliated hospital of Hunan Normal University)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age >=18 years; severe acute pancreatitis; informed consent was obtained from the patient or family members.

Exclusion criteria

Exclusion criteria: Patients presenting with any perineal or perianal skin lesions (such as incontinence-associated dermatitis, pressure injuries, skin tears, etc.) upon admission; patients with dermatological conditions that may interfere with the assessment of incontinence-associated dermatitis; or those who withdraw from the study prematurely.

Design outcomes

Primary

MeasureTime frame
Incidence of incontinent dermatitis;IAD severity;

Secondary

MeasureTime frame
Cost-effectiveness ratio;Incremental cost-effectiveness ratio;Sensitivity Analysis;

Countries

China

Contacts

Public ContactGan Xiaoqing

Hunan Provincial People's Hospital (the first affiliated hospital of Hunan Normal University)

ganxiaoqing2020@sina.com+86 83929421

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026